Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Dev Neurobiol. 2019 Jun 9;79(7):664–683. doi: 10.1002/dneu.22700

Table 5.

Comparison of cytoskeletal and presynaptic related gene expression levels between genotypes and treatments

Gene Mmu 2N+ fold of 2N Ts fold of 2N Ts+ fold of 2N Ts+ fold of Ts
Cytoskeletal
 Gabarap 11 8.87** 8.16** 2.05 0.25**
 Tubb4b 2 3.29** 3.01** 0.81 0.27**
 Nefh 11 1.16 1.62 0.88 0.54**
 Dbn1 13 1.05 1.13 2.13** 1.88**
 Sncg 14 1.06 1.11 4.94** 4.46**
 Dcx X 0.97 1.02 2.22** 2.17**
 Cav2 6 0.93 0.92 1.37 1.48*
 Cav3 6 0.87 0.84 1.46** 1.74**
 Dync1h1 12 0.86 0.37* 0.77 2.08*
 Synpo 18 0.05** 0.06** 0.07** 1.06
Presynaptic
 Syngr1 15 0.89 14.64** 0.99 0.07**
 Snap29 8 2.21** 1.13 1.38 1.22
 Bsn 9 0.91 1.00 0.65 0.66*
 Snca 6 0.26** 0.33** 0.61* 1.87

Mus musculus chromosome using build Grmc38, NT denotes not triplicated;

2N, disomic mice, Ts, Ts65Dn,

+

, maternal choline supplementation;

**

, p < 0.005;

*

, p < 0.01